Global Retinoids Market Soars Natural Skincare Trend and Acne Concerns Drive Growth reach US$ 2.5 billion by 2032, with a projected CAGR of 5.4%  

Retinoids Market
Retinoids Market

The global retinoids market is experiencing a surge in popularity, poised to reach a staggering US$ 2.5 Billion by 2032. This significant growth, estimated at a CAGR of 5.4% between 2022 and 2032, reflects a shift towards less invasive skincare solutions and a growing focus on natural ingredients.

Get Recently Updated Report of Market as Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-8060

Dermatologists Embrace Retinoids as Effective Topical Treatment

The increasing preference for non-surgical procedures is fueling the demand for retinoids. Dermatologists are recognizing the efficacy of retinoids in treating various skin concerns, making them a popular choice for both pre- and post-surgical care. Furthermore, the growing demand for natural and organic skincare solutions aligns perfectly with the benefits offered by retinoids.

Acne Concerns Drive Market Expansion and Product Diversification

The global rise in acne cases is another key driver of the retinoids market. Manufacturers are capitalizing on this trend by incorporating retinoids into a wider range of products, including moisturizers, anti-wrinkle creams, sunscreens, and even nail care products. This diversification caters to a broader audience seeking effective solutions for various skin issues.

Key Takeaways from Retinoids Market:

  • North America, led by the US, holds more than 30% of the market share. This could be credited to rising incidences of skin disorders and facial acne over here.
  • Europe stands second with Germany leading from the front. It holds more than 10% of the market share. This could be reasoned with enhancements in healthcare infrastructure with growing awareness about appropriate skincare regimen and utilization of retinol and various other ingredients in the cosmetic medications and products.
  • Coming to the Asia-Pacific, Japan holds more than 9% of the market share; due to an ever-increasing utilization of retinoids in skin care medication and dermatology. Research states that Japan was home to nearly 3,050 general hospitals as of October 2020. Call to look better irrespective of age is driving adoption of the cosmetic products containing good quantity of retinoids for improving level of collagen in the body.
  • Synthetic retinoids overpower conventional ones in terms of pharmacological qualities as they pass through specific RAR (retinoic acid receptors), which are capable of reducing side-effects.

Enrich Your Thinking With Our Comprehensive Methodology Now: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-8060

Competitive Arena:

  • Bausch Health Companies Inc., through its dermatology division “Ortho Dermatologics”, delivered 4 presentations at the Florida Society of Dermatology Physician Assistants (FSDPA). They covered novel clinical data related to SILIQ, DUOBRIL, and JUBLIA injection, along with several encore presentations.
  • Differin, the very first consumer acne medication approved by the US FDA and doled out by Galderma Laboratories, L.P., has started getting subjected to an audio and a digital advertising campaign that would translate into strategic partnership with Acast Creative.
  • The US FDA, in August 2018, approved once-daily retinoid product termed as “Altreno” floored by Ortho Dermatologics to treat patients aged 9 and above.

What does the Report Cover?

  • Future Market Insights offers an exclusive perspective and various real-time insights on the retinoids market in its latest study, presenting historical demand assessment of 2016 – 2021 and projections for 2022 – 2032.
  • The research study is based on type (natural retinoids and synthetic retinoids), by application (acne, psoriasis, anti-aging, and likewise), and by distribution channel (hospitals pharmacies, online pharmacies, retail pharmacies, and hypermarkets/supermarkets).

Key Companies Profiled:

  • GlaxoSmithKline Inc.
  • Mylan Pharmaceuticals Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • Ortho Dermatologics

Get Ahead with Detailed Market Intelligence: Purchase Now to Access: https://www.futuremarketinsights.com/checkout/8060

Key Market Segments Covered in Retinoids Industry Research:

By Type:

  • Natural Retinoids
  • Synthetic Retinoids

By Application:

  • Acne
  • Psoriasis
  • Anti-aging
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Supermarkets / Hypermarkets

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *